Stay updated on Epacadostat & Nivolumab Combo in Immune Therapies Clinical Trial

Sign up to get notified when there's something new on the Epacadostat & Nivolumab Combo in Immune Therapies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Epacadostat & Nivolumab Combo in Immune Therapies Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Page revision tag updated from v3.4.3 to v3.5.0; the new Revision: v3.5.0 appears and the old Revision: v3.4.3 tag is removed.
    Difference
    0.0%
    Check dated 2026-03-18T17:49:57.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3. No visible changes to study details or page layout.
    Difference
    0.0%
    Check dated 2026-03-11T16:28:35.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Removed the lapse-in-government-funding notice and Revision: v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-11T02:31:14.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Notice added about a lapse in government funding with information to check cc.nih.gov and opm.gov; page revision updated from v3.4.0 to v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-03T23:37:21.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The page now adds a 'Show glossary' option and updates footer metadata to include 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', along with a 'No FEAR Act Data' notice. These are non-critical UI and metadata updates that do not affect core study content.
    Difference
    0.2%
    Check dated 2026-01-27T21:19:13.000Z thumbnail image
  8. Check
    104 days ago
    Change Detected
    Summary
    Added a consolidated Locations section listing Alabama, California, North Carolina, and Tennessee. Removed the HHS Vulnerability Disclosure link and updated the page to revision v3.3.3.
    Difference
    0.4%
    Check dated 2025-12-22T22:23:47.000Z thumbnail image

Stay in the know with updates to Epacadostat & Nivolumab Combo in Immune Therapies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Epacadostat & Nivolumab Combo in Immune Therapies Clinical Trial page.